NCT06067750View on ClinicalTrials.gov

Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

May 25, 2024

Study Completion Date

May 25, 2024

Conditions
Traumatic Brain InjurySubarachnoid HemorrhageIntracerebral HaemorrhageEncephalitisAcute Ischemic StrokeStatus EpilepticusSeizuresSubdural HematomaICP (Intracranial Pressure) Increase
Interventions
DIAGNOSTIC_TEST

Narcotrend compared to Cerebral Function Analysing Monitor (CFAM)

All patients will receive Narcotrend and CFAM monitoring in this observational study

Trial Locations (1)

NG7 2UH

Nottingham University Hospitals Trust, Nottingham

All Listed Sponsors
lead

Nottingham University Hospitals NHS Trust

OTHER